B. G. Cooper (Birmingham, United Kingdom), G. Nolan (Dublin, Ireland)
IsovolumeFEF25-75%6 and FEV1 for identifying bronchodilator response M. P. Swanney, L. E. Beckert, C. M. Frampton, R. L. Jensen, R. O. Crapo (Christchurch, New Zealand; Salt Lake City, United States Of America)
| |
Reproducibility of FEV6 and FVC measurement: dependence on degree of obstruction D. Schuermans, J. Vandevoorde, S. Verbanck, L. Callebaut, W. Vincken (Brussels, Belgium)
| |
Stroke volume at rest and during exercise in upright and supine position measured by acetylene uptake in healthy controls H. Groepenhoff, S. Holverda, A. Boonstra, P. E. Postmus, A. Vonk-Noordegraaf (Amsterdam, Netherlands)
| |
Oscillometric lung function measurements and cold air exercise challenge outcomes J. Driessen, B. Thio, F. D. Jongh (Enschede, Netherlands)
| |
Reporting specific airway resistance (sRaw) in children: mean or median? L. Welsh, S. Lum, C. Oliver, J. Stocks (London, United Kingdom)
| |
Centralised quality assurance (QA) for PFTs in a multi-center inhaled insulin trial R. L. Jensen, R. Crapo, B. Sun, D. B. Muchmore (Salt Lake City, Indianapolis, United States Of America)
| |
First phase of a quality assurance audit of respiratory function laboratories within Scotland R. Carter, C. Downie, J. Lennie, B. Oatway, J. Leys, A. Stevenson (Glasgow, United Kingdom)
| |
Quality control of respiratory measurements in global trials A. J. Harrison, H. Urbanski, E. M. Moore (Maidenhead, Maids Moreton, United Kingdom)
| |